At long last, Amgen/UCB score FDA okay for EvenityAmgen and UCB finally have FDA approval for osteoporosis drug Evenity, two years after it was turned down Share XAt long last, Amgen/UCB score FDA okay for Evenityhttps://pharmaphorum.com/news/at-long-last-amgen-ucb-score-fda-okay-for-evenity/
Amgen and UCB re-file Evenity for US approvalAmgen and UCB have resubmitted their application for US approval of Evenity as an osteoporosis treatment, hoping that Share XAmgen and UCB re-file Evenity for US approvalhttps://pharmaphorum.com/news/amgen-ucb-evenity-fda-filing/
